SCHEMBL20745948

SCHEMBL20745948

O=C(O)c1ccnc(N2CCS(O)(O)CC2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RBP4 P02753 2/20 0.43
TTR P02766 1/20 0.42
KDM4E B2RXH2 4/20 0.41
KDM5A P29375 1/20 0.41
JMJD1C Q15652 1/20 0.41
KDM3A Q9Y4C1 1/20 0.41
ACHE P22303 3/20 0.40
MAPK8 P45983 1/20 0.40
CDC7 O00311 1/20 0.40
SLC6A7 Q99884 2/20 0.37
CYP2C19 P33261 1/20 0.36
HCAR2 Q8TDS4 1/20 0.36
ALDH1A1 P00352 1/20 0.36
GNE Q9Y223 1/20 0.36
WNT1 P04628 1/20 0.35
DYRK1A Q13627 1/20 0.35
ALOX15 P16050 1/20 0.35
TSHR P16473 1/20 0.35
ACMSD Q8TDX5 1/20 0.35
TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20745949 0.88 ACHE (0.52) RBP4TTRKDM4EKDM5AJMJD1C
SCHEMBL28070878 0.84 MAPK8 (0.52) RBP4TTRKDM4EKDM5AJMJD1C
SCHEMBL15188017 0.83 ACHE (0.49) RBP4TTRKDM4EACHESLC6A7
SCHEMBL22262452 0.83 CRBN (0.52) RBP4KDM4EACHECYP2C19ALDH1A1
SCHEMBL28087268 0.83 MAPK8 (0.54) RBP4TTRKDM4EKDM5AJMJD1C
SCHEMBL3116636 0.80 POLB (0.54) RBP4KDM4EACHEALDH1A1
SCHEMBL31706055 0.80 POLB (0.54) RBP4KDM4EACHEALDH1A1
SCHEMBL28059123 0.80 ADRB1 (0.54) RBP4TTRKDM4EKDM5AJMJD1C
SCHEMBL31706765 0.78 RBP4 (0.44) RBP4TTRKDM4EKDM5AJMJD1C
SCHEMBL31346934 0.78 RBP4 (0.45) RBP4TTRKDM4EKDM5AJMJD1C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3668502-A1 MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE AbbVie Inc. (US) 2020-06-24 EP disclosed
WO-2019035927-A1 MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE ABBVIE INC. (US) 2019-02-21 WO disclosed